$
1. 02
-0.04
-3.7736%
$
5.95M Market Cap
- P/E Ratio
- Div Yield
55,500 Volume
- Eps
$ 1.06
Previous Close Investors:
Want to track IMNN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Imunon's stock rockets after ovarian cancer treatment's positive trial results
Shares of Imunon Inc. skyrocketed on massive volume Tuesday, after the biotechnology company announced positive survival data from a trial of its ovarian cancer treatment, IMNN-001.
Marketwatch | 2 years ago
Why Is Imunon (IMNN) Stock Up 259% Today?
Imunon (NASDAQ: IMNN ) stock is rocketing higher on Tuesday as the clinical-stage company releases data from a Phase 2 clinical trial of IMNN-001. This is the company's treatment candidate for patients with advanced ovarian cancer.
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
